Broadest ever therapeutic HPV vaccine to be tested in clinical trial
by Nicola Davis from Science | The Guardian on (#4XC9R)
Treatment could clear up persistent infections and reduce risk of cervical cancer
The broadest vaccine yet that could clear up persistent HPV infections and reduce the risk of women developing cervical cancer is to be tested in a clinical trial.
Human papillomavirus infections are common and are generally cleared by the body. However, about 10% of infections are not cleared, with persistent infections of certain types of HPV known to increase the risk of a number of cancers, including cervical cancer.
Continue reading...